Unparalleled Technology for Kinase Drug Discovery and Development

ActivX has pioneered the commercialization of Activity-Based Protein Profiling (ABPP). Starting with serine hydrolases, ActivX has developed novel platforms and probes to broadly and accurately profile pharmaceutically-relevant protein activities directly in biological samples.

KiNativTM brings the power of ABPP to the functional analysis of native protein kinases ... more

 

Recent News & Publications

• Thermo Fisher Scientific Licenses Novel Activity-Based Protein Profiling Technology from ActivX Biosciences, Inc.
• KiNativTM Brochure
• The new Lipid Kinases panel
• Biochemistry Paper - 2nd Most-Cited Article Published in 2007
• Chemical Engineering News
• Annual Review in Biochemistry